Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 2/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | HNF4A | P41235 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10617137 | 0.84 | ESR2 (0.55) | ESR2HDAC4HDAC2HDAC8HDAC6 | |
| Methane SCHEMBL28025030 | 0.83 | ESR2 (0.53) | ESR2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL9469704 | 0.83 | ESR2 (0.53) | ESR2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL2865463 | 0.83 | BACE1 (0.50) | ESR2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL8067080 | 0.83 | TDP2 (0.40) | ESR2BACE1ELANEALOX5POLB | |
| SCHEMBL1513737 | 0.83 | ESR2 (0.53) | ESR2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL339799 | 0.81 | TDP2 (0.44) | ESR2ELANEPOLBRECQLNPSR1 | |
| SCHEMBL4473038 | 0.80 | TDP2 (0.46) | ESR2BACE1ALOX5ALDH1A1PDCD1 | |
| SCHEMBL2400343 | 0.79 | ESR2 (0.48) | ESR2BACE1ALOX5POLBALDH1A1 | |
| SCHEMBL30804714 | 0.79 | ESR2 (0.48) | ESR2BACE1ALOX5POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1494995-A1 | 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS | Wella Aktiengesellschaft (DE) | 2005-01-12 | — | — | EP | claimed |
| WO-2003087034-A1 | 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2003-10-23 | — | — | WO | claimed |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| CN-118204116-A | Catalyst for preparing p-cresol by toluene shape-selective hydroxylation and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2024-06-18 | — | — | CN | disclosed |
| CN-117443446-A | Preparation method of catalyst for preparing p-cresol from toluene and preparation method of p-cresol | 中国天辰工程有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117443445-A | Preparation method of catalyst for preparing m-cresol from toluene and preparation method of m-cresol | 中国天辰工程有限公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-4202013-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | Fushimi Pharmaceutical Co., Ltd. (JP) | 2023-06-28 | — | — | EP | disclosed |
| CN-116194552-A | Cyclic phosphazene compounds having oxaphosphaphenanthrene-containing ring structure | 株式会社伏见制药所 | 2023-05-30 | — | — | CN | disclosed |
| CN-110683940-B | Method for converting dibenzo [ c, e ] [1,2] oxathiane-6-oxide compound | 中国科学院成都生物研究所 | 2022-07-01 | — | — | CN | disclosed |
| CN-108430970-B | Bisphenol compound and aromatic polycarbonate | 本州化学工业株式会社 | 2022-03-11 | — | — | CN | disclosed |
| CN-108430970-A | Bisphenol compound and aromatic copolycarbonate | 本州化学工业株式会社 | 2018-08-21 | — | — | CN | disclosed |
| CN-106000442-B | Ortho-chlorotolu'ene hydrolyzes the preparation method of metacresol special-purpose catalyst processed | 江苏钟腾化工有限公司 | 2018-07-10 | — | — | CN | disclosed |
| CN-106000442-A | Preparation method of catalyst specially used for preparing m-cresol by hydrolyzing o-chlorotoluene | 江苏钟腾化工有限公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-106008170-A | New green process for preparing high-purity m-cresol | 江苏钟腾化工有限公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105906481-A | P-cresol preparation method and equipment | 金能科技股份有限公司 | 2016-08-31 | — | — | CN | disclosed |
| CN-103288602-B | Method for preparing p-cresol from anisole and preparation method of used catalyst thereof | DALIAN CHEMICAL PHYSICS INST | 2014-12-10 | — | — | CN | disclosed |
| CN-103288602-A | Method for preparing p-cresol from anisole and preparation method of used catalyst thereof | DALIAN CHEMICAL PHYSICS INST | 2013-09-11 | — | — | CN | disclosed |
| CN-102807475-A | Method for preparing orthocresol and metacresol | ANHUI HAIHUA SCIENCE & TECHNOLOGY CO LTD | 2012-12-05 | — | — | CN | disclosed |
| CN-101107388-B | Method for producing plated resin formed article | DAICEL POLYMER LTD | 2012-06-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | PFAS, PHOSPHO1, PAF1 | ESR2 1224/4885HDAC4 2824/4885HDAC2 1570/4885 |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | PFAS, PHOSPHO1, PAF1 | ESR2 1224/4885HDAC4 2824/4885HDAC2 1570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.